About
"De-risking the commercialisation of Health-Tech innovations" We provide expert advice on the commercialisation of biotech and medtech innovations, beyond the Regulatory Clearances, i.e. Health Economics, Reimbursement, Distribution and most importantly Adoption. Med2Mark thoroughly assesses the commercial value of Health-Tech innovations before significant investments are committed. We are an international boutique Consulting Practice with over twenty years' experience in the commercialisation of Biotech and Medtech innovations in the USA, Europe, Asia and Australia
Technologies
Route 53GmailGoogle AppsHotjarGoogle Tag ManagerMobile FriendlyLinkedin LoginWordPress.orgGoogle Font APILinkedin WidgetAndroidIoTNode.js
Keywords
management kpisstrategic planninghealth economicsmedical technologiesadoptionbiotechnologieskey opinion leadersstrategic alliancesprivate equitysales incentivesstartupventure capitaldistributionreimbursementcommercialisationproduct launchmarket developmenthealthcare market entrymarket accessdiagnostic toolspersonalized medicinehealthcare innovationearly adoption strategiesbiotechnologyhealth impact assessmentb2bdigital healthmedical standards compliancenice meta toolmarket assessment
Company Information
- Employees1
- Founded2011
Location
49 Studley Park Rd, Melbourne, Victoria, Australia, 3101
